ctDNA Provides Prognostic and Predictive Value in Early-Stage Breast Cancer
Circulating tumor DNA can be used as a predictive measure of response to neoadjuvant chemotherapy and inform overall prognosis in patients with early-stage breast cancer, providing information that can be used to tailor treatment.
Source: OncLive